fincash logo SOLUTIONS

Fincash » Search » Ipca Laboratories Ltd

Ipca Laboratories Ltd

Updated on January 20, 2020

Stock/Share Code - IPCALAB

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)

Below is the details of IPCALAB Ipca Laboratories Ltd

Market Cap₹14,437 Cr.
Current Price ₹1,064.2 as on 10 Dec 19
52 Week High / Low Price₹1,188.3 / ₹717
Face Value₹2
Stock P/E24.15
Book Value₹270.27
Dividend Yield0.26 %
ROCE16.53 %
ROE15.39 %
Sales Growth (3yrs)8.75 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free.
Cons: Stock is trading at 4.23 times its book value The company has delivered a poor growth of 2.19% over past five years. Company has a low return on equity of 10.94% for last 3 years.

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹170.05 24.93 ₹107,934.08 Cr. 0.61 ₹1,064.09 Cr. 57.62 17.09 8123.35 11.19
2. Dr Reddy's Labs ₹2,897.5 17.68 ₹48,412.38 Cr. 0.69 ₹1,106.8 Cr. 113.54 26.07 4812.80 12.42
3. Cipla ₹453.05 22.78 ₹37,626.53 Cr. 0.64 ₹474.5 Cr. 25.85 9.57 4395.78 10.94
4. Piramal Enterp. ₹1,611.6 17.30 ₹36,008.74 Cr. 1.43 ₹554.69 Cr. 17.26 14.61 3603.56 9.42
5. Biocon ₹289.65 43.30 ₹33,798 Cr. 0.18 ₹215.7 Cr. -24.60 19.02 1572.20 13.39
6. Torrent Pharma. ₹13.65 37.89 ₹32,128.11 Cr. 0.90 ₹244 Cr. 36.31 5.86 2005.00 12.66
7. Aurobindo Pharma ₹432.55 9.99 ₹26,361.38 Cr. 0.56 ₹639.86 Cr. 2.69 17.87 5600.47 18.45
8. Ipca Labs. ₹152.9 24.15 ₹14,436.99 Cr. 0.26 ₹196.02 Cr. 63.70 21.52 1212.56 16.53

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ipca Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
YOY Sales Growth %9.38%6.49%-16.53%-2.23%14.58%16.84%19.7%15.4%10.24%6.69%18.39%21.52%
Material Cost %32.35%34.66%37.51%34.12%34.19%32.75%32.52%31.4%31.63%32.26%35.86%33.78%
Employee Cost %21.47%23.73%24.48%21.65%21.21%21.57%22.88%20.42%18.6%21.21%20.33%18.12%
Operating Profit1067122149162109114173232175195262
OPM %14%11%3%17%19%14%13%17%24%21%19%22%
Other Income646111113141413151914
Profit before tax6426-211101237278141197141168227
Tax %35%-73%5%12%14%28%16%15%19%23%21%14%
Net Profit4144-20961065166120160109132196
EPS in Rs3.283.52-1.607.648.374.075.199.4812.688.6710.4515.51

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales Growth %13.77%21.16%22.19%21.49%23.83%19.28%16.43%-4.54%-9.2%10.65%2.94%12.91%%
Material Cost %46.13%41.21%43.25%40.8%38.95%39.27%34.85%37.02%37.33%35.7%34.84%32.16%%
Manufacturing Cost %7.44%7.23%6.3%6.63%7.35%10.45%7.94%9.53%9.83%9.24%9.4%8.88%%
Employee Cost %13.39%14.11%13.39%13.91%13.83%13.55%14.77%17.53%21.52%21.76%22.32%20.86%%
Other Cost %17.73%24.38%17.11%16.19%19.93%16.55%19.68%18.71%21.47%19.29%19.51%18.79%%
Operating Profit160166309423464561736531276435445696863
OPM %15%13%20%22%20%20%23%17%10%14%14%19%22%
Other Income732441-2121921332821405561
Profit before tax177114272334369461629358111258283557733
Tax %20%20%23%23%24%28%24%28%17%27%18%18%
Net Profit1419120925528033147725693188233455598
EPS in Rs10.986.933.2519.7921.7425.6037.8320.297.3314.9218.4736.0047.31
Dividend Payout %14%30%17%16%14%15%13%5%0%7%5%8%

Compounded Sales Growth

  • 10 Years:: 11.02%
  • 5 Years:: 2.19%
  • 3 Years:: 8.75%
  • TTM:: 14.66%

Compounded Profit Growth

  • 10 Years:: 16.26%
  • 5 Years:: -1.16%
  • 3 Years:: 71.53%
  • TTM:: 74.70%

Return on Equity

  • 10 Years:: 19.02%
  • 5 Years:: 10.45%
  • 3 Years:: 25.78%
  • 1 Year:: 43.46%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital25252525252525252525252525
Equity Capital25.0924.9925.0425.1425.1725.2425.2425.2425.2425.2425.2425.2725.27
Other Liabilities2162822973344725286486718128358619601,010
Trade Payables66.6965.4669.31184.17258.05218.82295.32344.01444.5371.39385.73413.86539.96
Total Liabilities1,1771,3701,6261,9182,3352,7153,2243,8333,9604,0264,1834,5414,866
Fixed Assets4135636366989131,0751,3061,7531,9771,9461,8551,7401,752
Gross Block577.09763.99878.47985.581284.511524.851851.292465.92137.322276.992358.722412.97
Accumulated Depreciation164.38200.96242287.76371.69449.52545.18712.94160.74331.02504.11672.87
Other Assets6047349021,0771,2851,4881,7241,7321,7571,7732,0402,4132,634
Trade receivables263.76342.77391.91369.87345.11415.93448.76353.55441.45501.98594.38632.06864.67
Cash Equivalents7.595.848.298.449.2554.6669.22113.19161.9817.53131.03259.81252.48
Loans n Advances73.3385.23130.52196.1182.91186.62232.93218.91220.06262.93314.67331.17126.58
Other Assets etc00039.9283.4797.66134.97128.91101.92117.45126.42134.07267.88
Total Assets1,1771,3701,6261,9182,3352,7153,2243,8333,9604,0264,1834,5414,866

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity110155194215222387515455696271324487
Profit from operations186.44268.57337.49380.76519.08578.6763.45539.76312.72420.02467.83723.43
Working Capital Changes-46.05-90.06-97.55-102.16-216.85-100.02-118.48-9.96412.34-94.56-86.56-128.87
Taxes paid-30.08-23.59-46.42-64.03-79.9-91.73-130.19-74.46-29.06-54.32-57.41-107.66
Cash from Investing Activity-145-106-127-199-228-261-362-686-214-146-119-114
Fixed Assets Purchased-143.7-78.75-143.44-194.62-239.38-228.55-371.14-554.87-241.76-134.53-72.32-67.41
Fixed Assets Sold0.890.631.011.260.951.180.811.561.671.021.78
Investments purchased-574.97-481.68-481.95-618.27-1315.61-1805.99-1903.12-2037.90-2100-2456.04-2613.92
Investments sold570.48455.32491.1610.411315.611832.391906.22046.14.192107.372462.622622.67
Cash from Financing Activity37-51-64-176-81-138255-414-156-130-223
Proceeds from Shares1.772.312.562.190.760.31000004.57
Proceeds from Borrowings88.8215.0271.2195.63137.23110.3966.9487.75151.8367.761.390
Repayment of Borrowings-14.79-48.16-69.05-41.54-81.47-96.92-110.85-109.63-517.2-196.01-181.79-195.34
Interest Paid-16.86-29.37-28.78-29.22-36.7-34.3-28.29-31.28-28.45-22.84-22.48-16.66
Dividends Paid-21.94-33.62-37.87-43.86-46.66-46.78-66.12-36.85-15.34-0.24-15.33-15.4
Net Cash Flow2-22-1145142568-3174150

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %24%16%25%26%24%24%27%13%4%9%9%17%
Debtor Days929992725455514257596864
Inventory Turnover4.254.534.624.514.143.984.123.523.213.643.663.74

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Ipca Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.